From: World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
Patient characteristics | Antimalarial | Methodology | Pharmacokinetic parameters |
---|---|---|---|
Malaria status [1] | Generic name | Sampling times (to include sampling on day of recurrence of parasitemia) | Day 7 concentration (median, IQR, range) |
Age | Dose (total) | Sample Matrix (e.g. Venous blood, capillary blood, filter paper spot, breast milk, placenta, urine, saliva) | AUC (median, IQR, range) |
Weight | Manufacturer | Assay method | Pharmacokinetic model |
Gender | Route of administration | Assay Validity [3] | Â |
Sample size | Â | Sample volume | Â |
Special Risk Group [2] | Â | Sample storage (temperature and duration) | Â |